

M&A Climate & Current Market Dynamics
Information
With over $1 trillion in M&A deals in the previous eight years, this trend in activity shows no signs of slowing with private equity firms capitalizing on the highly fragmented CDMO space and a predicted surge in activity in the biologics and cell & gene as more treatments are approved.
This webinar will address the benefits of private equity ownership, in triggering new growth, enabling greater strategic focus, increasing prioritization on M&A and better utilization of internal funds for organic growth initiatives.
Discussion points:
Update on current M&A landscape
How to optimally position a company for first-time external
investment
Life under PE: strategic support to the company’s management
team,
The investor view: financing organic growth



